Authorized reseller of Access Bio & Celltrion Rapid COVID-19 Antigen Tests (2 Pack). Please contact for more details whether one time buy or contract orders.
We have iHeath finally OTG LA California .... ICPO/POF/CI/Inspect and pay at iHealth warehouse... 8.50+ depending on quantity.....
Official Sales Partner for Master Distributor of iHealth Rapid Test NOT A BROKER OR RE-SELLER AVAILABLE FOR IMMEDIATE DELIVERY IN THE USA FDA AUTHORIZED 15 MINS SELF-TEST Product Description The iHealth COVID-19 Antigen Rapid Test is a lateral flow assay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with adult-collected nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older, or adult collected anterior nasal swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. Pricing: $9 PER KIT OF 2 TESTS MOQ: 1 pallet: 84 cartons / 7560 boxes / 15,120 tests Maximum Quantity: Please inquire Shipping Information: 90 Packs per Carton, 2 Tests per Pack 1 pallet: 84 cartons / 7560 boxes 1100 lbs Per pallet Single Package Dimensions (LxWxH) 6.18 x 3.19 x 0.71 Inches Single Package Weight (lb) 0.13 Carton Dimensions (LxWxH) 13.1 x 11.8 x 10.8 Inches Carton Weight (lb) 12.8 *Prices subject to change without notice
RAPID ANTIBODY/Finger Prick 10 to 15 Minute Results An antibody test is also known as a serology test looks for the presence of antibodies, which are specific proteins made in response to infections. It is effective at detecting the recent past SARS-CoV2 infection. This test can detect the body's IgM Antibody response in as little as 7 days (IgG in 14 days) from infection with CDC validated 100% specificity and 100% sensitivity. The highest accuracy serological test on the market FDA EUA Approved Manufactured by one of the leaders in lateral flow technology Results in 10-15 minutes FINGER PRICK NO LAB RESULTS REQUIRED
COVID finger prick, rapid antigen test, or rapid test, is a rapid diagnostic test suitable for point-of-care testing that directly detects the presence or absence of an antigen. It is commonly used for the detection of SARS-CoV-2, the virus that causes COVID-19. Rapid tests are a type of lateral flow tests that detect protein, distinguishing it from other medical tests that detect antibodies or nucleic acid, of either laboratory or point-of-care types. Rapid tests generally give a result in 1 to 15 minutes, require minimal training or infrastructure, and have significant cost advantages. NO Lab Required for results.
PRICE PER TEST $8.99 TEST BinaxNOW COVID-19 Ag Card For Rapid Detection of SARS-CoV-2 | FDA EUA | IVD Use | RX Only The BinaxNOW COVID-19 Ag Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset. Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in anterior nasal (nares) swabs during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Negative results should be treated as presumptive, do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. The BinaxNOW COVID-19 Ag Card is intended for use by medical professionals or trained operators who are proficient in performing rapid lateral flow tests. BinaxNOW COVID-19 Ag Card is only for use under the Food and Drug Administration's EUA. Kit Details Test Card: 40 cards with test strips Extraction Reagent: bottle containing 7.5 mL of extraction reagent Nasal swabs: 40 sterile, single use specimen sampling swabs Positive Control Swab: 1 each â??individually wrapped for single use Negative Control Swab: 1 each â??individually wrapped for single use Documentation: Product Insert, Procedure Card Performance Data Sensitivity: 97.1% Specificity: 98.5%
US FDA approved test kit 93.3% sensitivity in confirming COVID-19 cases. Nasopharyngeal test We have OTG and production deals
100 Percent USA Made FDA EAU and CE approved rapid Antigen and Antibody test kits.
We can provide Covid-19 Rapid Antigen Test. Test with reliable results within minutes. Made in the USA. Lateral flow assay, No equipment required, Results within 10 minutes, minimally invasive specimen collection, nasal swab, POC (in patient care setting). Detects SARS-CoV2 nucleocapsid protein antigen with ultra high performance. Identifies acute infection with 88.4% sensitivity and 100% specificity. Complies with FDA. Principals or Buyer's Mandates only. No broker chains. FOB or CIF. Minimum order 500000 test please.
Covid 19 detection kit, famous for efficient detection of Covid 19/coronaVirus made in south korea
Both COVID-19 and influenza A/B viruses (Flu A/B) can cause acute respiratory infections, and people are generally susceptible. These three viruses are highly contagious, spread quickly, have a short incubation period, and have a high incidence. Symptoms of COVID-19 and influenza may look similar; the main symptoms include fever, dry cough, fatigue, etc. With this combination test, healthcare workers can provide an accurate diagnosis to patients and treat them with the appropriate measures. Feature Results ready in 15 minutes Accurate diagnostic tool for active infection Easy to administer and read results Affordable, no need for instrument, highly portable Enable testing on a massive scale For healthcare workers use only
To help stop the spread of COVID-19, Singclean Medical has developed COVID-19 Antigen Test Kits saliva swab which is a solid phase immunochromatographic assay for the rapid, qualitative detection of antigen from COVID-19 in human saliva swab specimen. The test provides only a preliminary test result. Therefore, any reactive specimen with the COVID-19 Antigen Test kit (Colloidal Gold) must be confirmed with alternative testing method (s) and clinical findings. Advantage: Quick: results ready in 15 minutes Affordable: no need for instrument Accurate diagnostic tool for active infection Easy to administer and read results Enable testing on a massive scale Non-invasive: more comfortable than nasopharyngeal swab Warnings 1. Use fresh samples whenever possible. 2. Positive results do not rule out bacterial infection or co-infection with other viruses. 3. A negative result can occur if the quantity of the COVID-19 antigen present in the specimen is below the detection limits of the assay, or failed to collect the COVID-19 antigen. 4. Negative results do not rule out infection with COVID-19 and should not be used as the final or sole basis for treatment or patient management decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19. For a more accurate test result, repeat the tests or confirmed with other testing methods and clinical findings is recommended
CE Approved Covid-19 IgG/IgM Antibody Blood Test Kit can be used as an initial screening for qualitative and differential detection. Throughout testing the antibody of IgG and IgM immunoglobulins in human serum, plasma or blood, the test kit can show the result in a short time. Relative sensitivity 96.00%(192/200) Relative specificity 98.29%(806/820) Accuracy 97.84% (998/1020) Advantages Fast detection: 10 minutes to interpret the result; Easy to operate: no complex equipment required during test; Sensitive: the product has a higher sensitivity than PCR Nucleic Acid Global Network Singclean@COVID-19 lgG/gM Test Kit has been sold to more than 50 countries in the worid, like Brazil, Chie,Polandï¼?spain, Bolivia, Greece, Lihuania, Ecuador, Ukraine and Turkey. Precaution It is worth noting that the result of Covid-19 IgG/IgM antibody blood test should not be used as the only evidence of Coronavirus diagnosis. Professional doctors and clinical findings are necessary if the result of antibody test is positive. Besides, the test kit should be operated by professionals only. Use by individuals may cause deviation in test results. Limitation False negative and false positive could happen. If the antibody is lower than the detection level, especially in the 7 days of the onset of symptoms, a positive patient may also be diagnosed as negative.
CE Approved Singclean COVID-19Test Kit (Colloidal Gold Method) is a solid phase immunochromatographic assay for the rapid,qualitative detection of antigen from COVID-19 in human nasal swab specimen.This test provides only a preliminarytest result. Therefore, any reactive specimen with the COVID-19 Test Kit (Colloidal Gold Method) must be confimed with alternative testing method(s) and clinical findings. This rapid antigen test kit is the second test kit developed by Singclean Medical for COVID-19 testing on the basis of Colloidal Gold Method after Singclean COVID-19 lgG/IgM Test Kit, an antibody test, was launched globally in March. Advantage Results ready in 15 minutes Accurate diagnostic tool for active infection Easy to administer and read results Affordable, no need for instrument, highly portable Enable testing on a massive scale For healthcare workers use only Sensitivity 98.56% Sensitivity 99.03% Accuracy 98.84% Warnings 1. This test is not for at home testing, and should only be operated by healthcare workers. 2. Optimal assay performance requires strict adherence to the assay procedure described in this insert sheet. Inadequate or inappropriate sample collection, storage, and transport may cause false test results.
Korean made Gmate COVID-19 Saliva Antigen Test Kit is a rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human saliva specimens. This test is an aid to early diagnosis of SARS-CoV-2 infection in patients with clinical symptoms with SARS-CoV-2 infection. â?¢ 90.9% Sensitivity, 100% Specificity â?¢ Made in Korea â?¢ Easy to Use â?¢ Currently the only imported brand approved and fully registered with governments and medical / health agencies for professional and home use. Provides initial screening result only Disclaimer: Reactive specimens must be confirmed with alternative testing method(s)
10,000 Rapid Antigen Test 500 Boxes 20 Test Per Box CE CERTIFICATION
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare providers. Kit Includes 20 Test Devices 20 Assay Buffer 20 Extraction Vials and Caps 20 Specimen Collection Swabs 1 Positive and 1 Negative Control Swabs 1 Instructions for Use
[CONTENTS] (25) Test Kits (25) Individual Test Kits (25) Serum Pipets (1) Instruction For Use SENSITIVITY 100% | SPECIFICITY 97.3%
Lateral flow assay No equipment required Rapid results within 10 minutes Minimally invasive specimen collection (nasopharyngeal swabs) POC setting (i.e. in patient care settings) by medical professionals Detects SARS-CoV-2 nucleocapsid protein antigen with ultra high performance Identify acute infection wit 88.4% sensitive and 100% specificity 20 test/box 20 test devices 20 assay buffer 20 extraction vials and caps 20 specifimen collection swabs 1 positive and 1 negative control swabs 1 instructions for use
FDA EUA
